Intravitreal Ranibizumab Injection for the Treatment of Retinopathy of Prematurity

OBJECTIVES: To evaluate the efficacy of a single injection of 0.3 mg intravitreal ranibizumab for the treatment of retinopathy of prematurity (ROP). METHODS: We conducted this retrospective case series study at King Abdul Aziz Medical City, Riyadh, Saudi Arabia. Seventy-four eyes of 37 preterm infan...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Med Princ Pract
Autors principals: Aldebasi, Tariq, Guma, Muataz A., Bashir, Rabia, Al Saif, Saif, Altwaijri, Waleed A., Al Bekairy, Abdulkareem M.
Format: Artigo
Idioma:Inglês
Publicat: S. Karger AG 2019
Matèries:
Original Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6944941/
https://ncbi.nlm.nih.gov/pubmed/30995663
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000500310
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars